AOBO Announces New Product Launch
... of a broad range of
prescription and over
the counter ("OTC") products in China, today ... could
become one of AOBO's leading products over
time. We are confident in our
future growth ... of a broad range of prescription and over
products in China.
GenVec Reports Second Quarter 2009 Financial Results
... contract is valued at approximately $2 million over
GenVec received a ... This grant, valued at approximately $600,000 over
two years, will be used to identify new ... risks and uncertainties, which change over
time. Factors that may cause actual results to ...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
... 19,004 patients, with 1,807 restenoses reported over
a mean 29-month follow-up period. For the entire ... analyzing the underlying trends in our business over
time. Investors should consider these non-GAAP ... pharmaceutical and medical device company with over
1,500 dedicated employees. Angiotech discovers, ...
iCardiac Expands Sales and Marketing Team
... Adds Industry Veteran with over
Two Decades of Cardiovascular Core Lab Experience ... Director of Business Development. Ms. Boyle has over
two decades of experience in operations and ... iCardiac's COMPAS technology has been used for over
a decade in cardiac clinical trials conducted for ...
PDI Reports 2009 Second Quarter Financial Results
... wins expected to exceed $18 million in revenue over
Signed agreement with The Medical ... wins expected to exceed $18 million in revenue over
12 months in our Sales Services segment, two of ... similar companies across the industry. However, over
the second half of the year, we expect to see an ...
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... and expects to provide guidance on this progress over
the upcoming months.
Additionally, Amicus ... be recognized as revenue on a straight-line basis over
18 years from the date of the agreement. In the ... NEA's experienced management team has invested in over
650 companies, of which more than 160 have gone ...
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... last year. The strategic steps we have taken over
the last few years
are now delivering clear ... to resolve the remaining labeling
the next 4-8 weeks and we anticipate launch in ... approvals,
product launches planned over
the next two years include:
- MEZAVANT ...
Patent Attorney John Rizvi Speaks at FIME International Medical Expo
... establishments, according to the FDA (2007). over
20,000 Floridians work in this sector.
The ... held at the Miami Beach Convention Center, with over
500,000 square feet of exhibitor space. The four ... seen steady growth in the medical device industry over
the past ten years and John Rizvi, a patent ...
Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level
... and contract manufacturing services to over
pharmaceutical and biotech companies in the world. ChemPartner currently has
a team of over
1000 scientists including over
80 senior scientific leaders
with extensive ...
Biotech Hot in July Driven by Positive Drug Data and Acquisitions
... treatment against the inflammatory disease for over
50 years. Patients taking Benlysta plus a ... the company is planning a public offering of over
Other major biotech movers ... (44%) have a market cap below $100 million
112 companies have announced a corporate ...
Model predicts evolution of Mediterranean landscape following fires
... plants (by shoots or seeds), their distribution over
space and time, and the resources they compete ... some Holm oaks) and finally to a Holm oak forest over
a period of around 100 years. However, this ... says this model is able to represent landscapes over
areas in excess of 1,000 hectares on a map with ...
Caliper Life Sciences Reports Second Quarter 2009 Results
... represents organic revenue growth of 5 to 7% over
2008 pro forma revenue. In addition, the ... amortization and stock-based compensation over
the second half of 2009 and for the full year ... amortization and stock-based compensation over
the second half of 2009 and for the full year ...
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
... ended June 30, 2009, an increase of $63.9 million over
the same prior year period;
Total revenues ... June 30, 2009, an increase of $199.3 million over
the same prior year period;
On a GAAP ... basis, EMEA revenues increased by nearly 10% over
the prior year period. Higher revenues in France, ...
Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
... X-ray absorptiometry (DXA) scanning.
the six month treatment period, elagolix 150 mg ... by all of the efficacy assessments was maintained over
the entire study duration and consistent with ... evident for either dose of elagolix; treatment over
six months was generally safe and well tolerated. ...
Sanofi-aventis Announces Second Quarter 2009 Results
... April 1, 2008 - led to a 44% decline in net sales over
the first half.
Second-quarter net ... included Zentiva (net sales: euro 163 million). over
the first half, net sales in Europe rose by 1.8%, ... Excluding H5N1 contracts, growth was 11.3%. over
the first half as a whole, net sales were flat ...
NeoGenomics Reports Second Quarter 2009 Results
... be developing and validating the melanoma test over
the next six months and expect to launch it in ... opportunity to develop certain other cancer tests over
time, and to have Abbott as new 9.6% owner of our ... 87-90% and a specificity of approximately 95%. over
the next six months, we will be analyzing the ...
Sechrist Industries, World Leader in Hyperbaric Chambers, Announces Edward Pulwer as President/CEO
... Industries. Sechrist has been in business for over
30 years and maintains the largest installed base ... platform.
Mr. Pulwer joins Sechrist with over
25 years experience in medical technology, most ... other interests.
30 years, Sechrist Industries has been the global ...
PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
... working closely with the PROLOR team as chairman over
the past two years, I am very pleased to be ... that has been together in various capacities for over
23 years. Since its formation in October 2006, The Frost Group has invested over
$160 million in various companies and ...
Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
... applications command
the major market share with over
87 percent of PUFA being used in ... Modern biotechnology offers clear advantages over
the conventional mode
of production. In a sense, ... growth
strategies. Frost & Sullivan leverages over
45 years of experience in
partnering with Global ...
Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.
... are compared to even stronger sales in Q2 2008 over
Q1 2008. Quarterly comparisons and a ... collectively grew by 9% organically in Q2 2009 over
the prior year level, with an unfavorable ... institutions, hospitals and in industry. over
one million scientists and technologists use our ...
Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
... tract disease is also seen in elderly adults over
age 65 years similar to the severe illness ... million adults annually, including the elderly over
age 65 years. This virus is responsible for ... risks and uncertainties, which change over
time. Factors that may cause actual results to ...
SAFC Supply Solutions(R) Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements
... expertise, SAFC provides security of supply with over
100,000 raw materials, of which 46,000 are ... and SAFC Hitech(R) - and had annual sales of over
$620 million in 2008. SAFC is a top 10 fine ... institutions, hospitals, and in industry. over
one million scientists and technologists use its ...
NEW Momentum(TM) Physician and Staff Scheduling Software for Imaging Centers, OB/GYN, and Other Specialty Practices Improves Productivity and Equity in Scheduling
... and patient and staff satisfaction. For over
20 years, Bio-Optronics has demonstrated ... and Momentum((TM)) workflow solutions, used in over
30 Veterans' Administration and other hospitals ... trial management systems, and are used in over
400 sites around the world.
Beta Release of v3.0 of OpenClinica Clinical Trials Software
... improvement in application speed for studies with over
10,000 subjects and over
1 million data points."
As open source ... and has a worldwide open source community of over
6,000 users and developers. All versions of ...
Accuri Cytometers Completes $4 Million Series D Financing
... in Switzerland. Credit Suisse is active in over
50 countries and employs approximately 46,700 ... companies. Founded in 2000, Flagship manages over
$600 million in early-stage funds and operates ... in Cambridge, MA. With an active portfolio of over
40 companies, the firm's strategy is to balance ...
Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
... that are completely absorbed by the body over
time and require repeat injections to maintain ... of Artefill has been extensively studied over
the past eight years. Since Artefill was approved in 2006, over
10 thousand patients have been treated ...
Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration
... and contract manufacturing services to over
pharmaceutical and biotech companies in the world. ChemPartner currently has a
team of over
1,000 scientists including over
80 senior scientific leaders with
Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
... at Ahmedabad, in the State of Gujarat. over
the last five decades, it has been developing and ... selling and distributing these in India and in over
50 countries around the world. Cadila ... curative pharmaceutical and diagnostic products. over
the last decade, Cadila Pharmaceuticals has ...
Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
... individuals experience progressive weight gain over
time. To date, the only highly effective ... Biomedical Research Center. "Providing the over
80 million overweight and obese Americans who ... Obesity Class III is BMI 40 kg/m2 or more. Of the over
100 million overweight and obese individuals in ...
New Report Just Published: World Prostate Cancer Therapeutics Market Report
... Differentiation II-4
New Therapies Appear over
the Horizon II-4
New Generation Prostate ... Acquisition II-75
Radiation Therapy Takes over
a North Carolina Treatment Center II-75
... Cancer II-77
MedMira Inks Agreement to Take over
Rights of a New Marker
2009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process
... focus of the study is highly relevant for people over
the age of 65. Assessing the combined effects of ... supplement, developed and marketed by Immunotec over
the past 10 years. It secured Health Canada ... with the Universite de Montreal and has built, over
the years, a close collaboration with McGill ...
Burrill & Company Invests in Taiwan Liposome Company
... by renowned scientist, Dr. Keelung Hong, who has over
30 years of research and development experience in liposomes with over
100 publications. TLC also has a team of ... The Burrill family of venture capital funds has over
$950 million under management and its merchant ...
Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
Mr. Hobbs has over
25 years of experience in the interventional ... has done an exceptional job leading the Company over
the past two-plus years and I look forward to ... of the tremendous progress our Company has made over
the past two and a half years. As we approach ...
NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State
... that it has raised additional gross funds of over
$4 million from institutional and private ... by NeoStem in the past two and half months to over
$15 million. In addition, affiliates of Suzhou ... their overall investment in the Company to over
$1,000,000. As part of its China expansion ...
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
... This is primarily driven by the rising interest over
the potential of kinase inhibitors in effectively ... San Jose, CA (PRWEB) June 30, 2009 -- With over
500 identified types of kinase proteins in the ... imatinib, among others, has ignited excitement over
the untapped potential of this very potent class ...
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma
... patients with cutaneous T-cell lymphoma. over
one percent (1%) of all people with CTCL in the ... dollars behind them. To date Yaupon has received over
$15 million in government support and over
$20 million in venture capital investment.
Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
... June 25 /PRNewswire-FirstCall/ --
1000 Members of the Research Community View ... Performance in a Multidisciplinary
1000 academic and government executives, ... for research
funding. The tool provides access to over
5,000 funding sources and includes
World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
... growing application segment for nanomedicine over
the years 2006 through 2015.
The ... size have been presented in terms of dollar sales over
the time period 2006-2015. The report enumerates ... market research publishers. The company employs over
800 people worldwide and publishes more than 1100 ...
Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM)
... through Sigma-Aldrich, bring the portfolio to over
6,100 antibodies powered by Atlas Antibodies
... (Nasdaq: SIAL ) today announced the release of over
2,300 antibody additions to its Prestige ... total number of highly validated antibodies to over
6,100. Developed by the Human Proteome Resource, ...
Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities
... totaling a contribution of CAN$ 30 million over
the next 2 1/2 years to be mainly used to bring ... of the Victhom Bionized subsidiary will be taken over
by Mr. Normand Rivard. "On behalf of Victhom, I ... his acting appointment, Normand Rivard took over
the role of Chief Executive Officer, and this ...